Olema Pharmaceuticals
OLMA
76 hedge funds and large institutions have $1.01B invested in Olema Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 15 reducing their positions, and 9 closing their positions.
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
87% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 15
10% more funds holding
Funds holding: 69 → 76 (+7)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.3% less ownership
Funds ownership: 93.17% → 92.88% (-0.3%)
3% less capital invested
Capital invested by funds: $1.05B → $1.01B (-$34.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$23.5M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$8.58M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.55M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.82M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$6.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$24.5M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$20.2M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$17.4M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$11.5M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$8.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACA
76
Avoro Capital Advisors
New York
| – | -$24.5M | -876,986 | Closed |
|
|
HA
77
HHLR Advisors
Grand Cayman,
Cayman Islands
| – | -$17.4M | -620,397 | Closed |
|
|
78
Franklin Resources
San Mateo,
California
| – | -$11.5M | -412,205 | Closed |
|
|
TCM
79
Tybourne Capital Management
Hong Kong
| – | -$6.71M | -239,996 | Closed |
|
80
Adage Capital Partners
Boston,
Massachusetts
| – | -$6.3M | -225,000 | Closed |
|
81
Point72 Asset Management
Stamford,
Connecticut
| – | -$2.24M | -80,000 | Closed |
|
|
TI
82
Trexquant Investment
Stamford,
Connecticut
| – | -$345K | -12,335 | Closed |
|
83
Ensign Peak Advisors
Salt Lake City,
Utah
| – | -$275K | -9,800 | Closed |
|
84
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$241K | -8,623 | Closed |
|
85
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | +$162 | +6 | New |
|
OLMA Hedge Fund Activity: Q3 2021 in Review
76 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q3 2021, worth a combined $1.01B — down 3.3% from $1.05B a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new OLMA positions and 9 closed out — a net gain of 8 holders — while 28 added to existing stakes and 15 trimmed.
The largest buyer was BlackRock, adding an estimated $23.5M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $24.5M sold.
- 76 institutional investors held Olema Pharmaceuticals (OLMA) as of Q3 2021, up from 69 in Q2 2021.
- Funds reported $1.01B of Olema Pharmaceuticals stock for Q3 2021, down 3.3% quarter-over-quarter.
- 17 funds opened new Olema Pharmaceuticals positions in Q3 2021 and 9 closed out, a net change of +8 holders.
- The largest Olema Pharmaceuticals buyer in Q3 2021 was BlackRock, an estimated $23.5M added.
- The largest Olema Pharmaceuticals seller in Q3 2021 was Avoro Capital Advisors, an estimated $24.5M sold.
Based on aggregated 13F filings for Q3 2021.